MoneyWorks4Me

The March 2022 quarter revenue stood at Rs. 2768.65 millions, up 6.04% as compared to Rs. 2610.86 millions during the corresponding quarter last year.Net Profit witnessed a 1906.02% growth almost the double from Rs. 8.64 millions to Rs. 173.32  millions  of same quarter last year.Operating profit for the quarter ended March 2022 decreased to 215.70 millions as compared to 327.00 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2768.65 2610.86 6.04 9429.27 11239.73 -16.11 9429.27 11239.73 -16.11
Other Income 90.78 49.06 85.04 420.68 473.71 -11.19 420.68 473.71 -11.19
PBIDT 215.70 327.00 -34.04 -14.87 1428.38 -101.04 -14.87 1428.38 -101.04
Interest 5.77 3.70 55.95 20.74 13.01 59.42 20.74 13.01 59.42
PBDT 209.93 323.30 -35.07 -35.61 1415.37 -102.52 -35.61 1415.37 -102.52
Depreciation 212.68 199.03 6.86 831.88 758.92 9.61 831.88 758.92 9.61
PBT -2.75 124.27 -102.21 -867.49 656.45 -232.15 -867.49 656.45 -232.15
TAX -176.07 115.63 -252.27 -313.18 115.63 -370.85 -313.18 115.63 -370.85
Deferred Tax -176.07 109.43 -260.90 -315.55 109.43 -388.36 -315.55 109.43 -388.36
PAT 173.32 8.64 1906.02 -554.31 540.82 -202.49 -554.31 540.82 -202.49
Equity 140.81 140.81 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 7.79 12.52 -37.80 -0.16 12.71 -101.24 -0.16 12.71 -101.24
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..